Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q3 2017 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BEIGENE LTD | 20 | Q3 2023 | 26.0% |
JD.COM INC | 20 | Q3 2023 | 13.1% |
IQIYI INC | 20 | Q3 2023 | 12.3% |
MONDELEZ INTL INC | 20 | Q3 2023 | 5.9% |
KINIKSA PHARMACEUTICALS LTD | 20 | Q3 2023 | 1.6% |
SOHU COM LTD | 20 | Q3 2023 | 0.6% |
PINDUODUO INC | 19 | Q3 2023 | 16.1% |
GOSSAMER BIO INC | 19 | Q3 2023 | 2.3% |
BRIDGEBIO PHARMA INC | 18 | Q3 2023 | 3.4% |
MELCO RESORTS AND ENTMT LTD | 18 | Q1 2023 | 2.8% |
View HHLR ADVISORS, LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
I-Mab | June 30, 2023 | 15,891,211 | 8.3% |
BeiGene, Ltd. | February 14, 2023 | 147,043,058 | 10.9% |
Gossamer Bio, Inc. | February 14, 2023 | 4,974,041 | 5.3% |
On Holding AG | February 14, 2023 | 5,468,504 | 1.9% |
Root, Inc. | February 14, 2023 | 138,977 | 1.5% |
Yatsen Holding Ltd | February 14, 2023 | 300,560,602 | 19.1% |
iQIYI, Inc. | July 11, 2022 | 149,075,912 | 5.0% |
Apellis Pharmaceuticals, Inc. | February 14, 2022 | ? | ? |
Beam Therapeutics Inc. | February 14, 2022 | ? | ? |
Futu Holdings Ltd | February 14, 2022 | 2 | - |
View HHLR ADVISORS, LTD.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-14 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
4 | 2024-02-01 |
View HHLR ADVISORS, LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.